Found: 92
Select item for more details and to access through your institution.
Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2227, doi. 10.1093/jac/dkae218
- By:
- Publication type:
- Article
Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Optimization of meropenem dosage in the critically ill population based on renal function.
- Published in:
- Intensive Care Medicine, 2011, v. 37, n. 4, p. 632, doi. 10.1007/s00134-010-2105-0
- By:
- Publication type:
- Article
Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 1, p. 33, doi. 10.1093/cid/ciae048
- By:
- Publication type:
- Article
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1473, doi. 10.1093/cid/ciae043
- By:
- Publication type:
- Article
Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 6, p. 1240, doi. 10.1093/cid/ciz845
- By:
- Publication type:
- Article
Reply to Cheng and Chuang.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1650, doi. 10.1093/cid/ciy749
- By:
- Publication type:
- Article
Antimicrobial Stewardship at Transitions of Care to Outpatient Settings: Synopsis and Strategies.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/antibiotics11081027
- By:
- Publication type:
- Article
Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis.
- Published in:
- Annals of Clinical Microbiology & Antimicrobials, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12941-021-00415-0
- By:
- Publication type:
- Article
Derivation of Meropenem Dosage in Patients Receiving Continuous Veno-Venous Hemofiltration Based on Pharmacodynamic Target Attainment.
- Published in:
- Chemotherapy (0009-3157), 2005, v. 51, n. 4, p. 211, doi. 10.1159/000086598
- By:
- Publication type:
- Article
Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 9, p. 1, doi. 10.1093/ofid/ofac468
- By:
- Publication type:
- Article
Optimising Dosing Strategies of Antibacterials Utilising Pharmacodynamic Principles: Impact on the Development of Resistance.
- Published in:
- Drugs, 2006, v. 66, n. 1, p. 1, doi. 10.2165/00003495-200666010-00001
- By:
- Publication type:
- Article
Cefditoren Pivoxil: A Viewpoint by Joseph L. Kuti.
- Published in:
- Drugs, 2002, v. 62, n. 4, p. 337, doi. 10.2165/00003495-200262020-00007
- By:
- Publication type:
- Article
Defining the potency of amikacin against <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Pseudomonas aeruginosa</em>, and <em>Acinetobacter baumannii</em> derived from Chinese hospitals using CLSI and inhalation-based breakpoints.
- Published in:
- Infection & Drug Resistance, 2018, v. 11, p. 783, doi. 10.2147/IDR.S161636
- By:
- Publication type:
- Article
Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles.
- Published in:
- Infection & Drug Resistance, 2008, v. 1, p. 51
- By:
- Publication type:
- Article
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 14, p. 1048, doi. 10.2146/ajhp170839
- By:
- Publication type:
- Article
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 1, p. e36, doi. 10.2146/ajhp170123
- By:
- Publication type:
- Article
Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, n. 1, p. e55, doi. 10.2146/ajhp150733
- By:
- Publication type:
- Article
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and –20 °C.
- Published in:
- American Journal of Health-System Pharmacy, 2014, v. 71, n. 17, p. 1480, doi. 10.2146/ajhp130664
- By:
- Publication type:
- Article
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 23, p. 2265, doi. 10.2146/ajhp100663
- By:
- Publication type:
- Article
Pharmacodynamic evaluation of i.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 17, p. 1619, doi. 10.2146/ajhp100569
- By:
- Publication type:
- Article
Impact of Order-Set Modifications and Provider Education Following Guideline Updates on Broad-Spectrum Antibiotic Use in Patients Admitted With Community Acquired Pneumonia.
- Published in:
- Hospital Pharmacy, 2022, v. 57, n. 4, p. 496, doi. 10.1177/00185787211055797
- By:
- Publication type:
- Article
Clostridium difficile Infection--Not Just a Burden Anymore.
- Published in:
- Connecticut Medicine, 2009, v. 73, n. 7, p. 407
- By:
- Publication type:
- Article
Elevated Vancomycin Minimum Inhibitory Concentrations among Methicillin-Resistant Staphylococcus aureus Isolated from Patients with Ventilator-Associated Pneumonia at a Connecticut Hospital.
- Published in:
- Connecticut Medicine, 2009, v. 73, n. 6, p. 337
- By:
- Publication type:
- Article
Critique of prevention of pneumococcal disease in high risk adults: A pharmacist‐based assessment of adult immunization protocols in clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Ceftaroline: A novel cephalosporin with methicillin-resistant Staphylococcus aureus and multidrug-resistant Streptococcus pneumoniae activity.
- Published in:
- Formulary, 2011, v. 46, n. 3, p. 71
- By:
- Publication type:
- Article
Ceftobiprole.
- Published in:
- Formulary, 2008, v. 43, n. 2, p. 66
- By:
- Publication type:
- Article
The use of antibiotic pharmacodynamic end points in incremental cost-effectiveness analyses.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 252
- By:
- Publication type:
- Article
Focus on... Posaconazole.
- Published in:
- Formulary, 2005, v. 40, n. 1, p. 13
- By:
- Publication type:
- Article
Daptomycin.
- Published in:
- Formulary, 2003, v. 38, n. 11, p. 634
- By:
- Publication type:
- Article
Focus on. . . Voriconazole A novel azole antifungal.
- Published in:
- Formulary, 2002, v. 37, n. 8, p. 387
- By:
- Publication type:
- Article
Drotrecogin alfa (activated).
- Published in:
- Formulary, 2001, v. 36, n. 11, p. 784
- By:
- Publication type:
- Article
Cefditoren pivoxil: A novel broad-spectrum oral cephalosporin.
- Published in:
- Formulary, 2001, v. 36, n. 4, p. 265
- By:
- Publication type:
- Article
Probability of Achieving Requisite Pharmacodynamic Exposure for Oral β-Lactam Regimens against Haemophilus influenzae in Children.
- Published in:
- Pediatric Drugs, 2008, v. 10, n. 6, p. 391, doi. 10.2165/0148581-200810060-00006
- By:
- Publication type:
- Article
Pharmacodynamic Target Attainment of Oral ß-Lactams for the Empiric Treatment of Acute Otitis Media in Children.
- Published in:
- Pediatric Drugs, 2008, v. 10, n. 5, p. 329, doi. 10.2165/00148581-200810050-00006
- By:
- Publication type:
- Article
Pharmacodynamic Evaluation of Meropenem and Cefotaxime for Pediatric Meningitis: A Report from the OPTAMA Program.
- Published in:
- Pediatric Drugs, 2006, v. 8, n. 2, p. 131, doi. 10.2165/00148581-200608020-00005
- By:
- Publication type:
- Article
Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 8, p. 658, doi. 10.1002/phar.2950
- By:
- Publication type:
- Article
Response to comment on "International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 2, p. 208, doi. 10.1002/phar.2907
- By:
- Publication type:
- Article
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 8, p. 736, doi. 10.1002/phar.2844
- By:
- Publication type:
- Article
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 8, p. 740, doi. 10.1002/phar.2842
- By:
- Publication type:
- Article
A guide to therapeutic drug monitoring of β‐lactam antibiotics.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 2, p. 220, doi. 10.1002/phar.2505
- By:
- Publication type:
- Article
Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5-Minute Infusion versus the Standard 30-Minute Infusion in Healthy Adult Volunteers.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 3, p. 266, doi. 10.1002/phar.1197
- By:
- Publication type:
- Article
Inappropriate Antibiotic Use Due to Decreased Compliance with a Ventilator-Associated Pneumonia Computerized Clinical Pathway: Implications for Continuing Education and Prospective Feedback.
- Published in:
- Pharmacotherapy, 2012, v. 32, n. 8, p. 755, doi. 10.1002/j.1875-9114.2012.01161.x
- By:
- Publication type:
- Article
Length of Stay and Hospital Costs Associated with a Pharmacodynamic-Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator-Associated Pneumonia.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 5, p. 453, doi. 10.1592/phco.30.5.453
- By:
- Publication type:
- Article
Cost-Effectiveness of Telavancin versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 12, p. 1471
- By:
- Publication type:
- Article
The Current State of Multidrug-Resistant Gram-Negative Bacilli in North America.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 2, p. 235, doi. 10.1592/phco.28.2.235
- By:
- Publication type:
- Article
Optimal Dosing of Piperacillin-Tazobactam for the Treatment of Pseudomonas aeruginosa Infections: Prolonged or Continuous Infusion?
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 11, p. 1490, doi. 10.1592/phco.27.11.1490
- By:
- Publication type:
- Article